导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.87% | 724/1050 |
| 近一周 | -4.50% | 1035/1104 |
| 近一月 | -5.76% | 685/1102 |
| 近一季 | -17.38% | 911/1092 |
| 近半年 | -15.55% | 900/1070 |
| 近一年 | 9.04% | 369/1018 |
| 近两年 | 60.38% | 427/926 |
| 近三年 | 43.77% | 299/834 |
| 成立以来 | 53.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.08% 650/1070 |
25.14% 335/1101 |
- - |
- - |
| 2025 | 52.18% 169/1065 |
14.24% 61/1014 |
7.62% 177/1038 |
14.16% 762/1050 |
8.42% 65/1065 |
| 2024 | 4.67% 437/1011 |
0.83% 272/960 |
1.12% 239/983 |
6.40% 847/991 |
-3.52% 571/1011 |
| 2023 | -9.67% 318/952 |
8.16% 167/880 |
-6.85% 636/895 |
-6.13% 372/915 |
-4.50% 453/952 |
| 2022 | -35.40% 704/867 |
-21.55% 609/773 |
7.90% 357/806 |
-15.68% 602/845 |
-9.51% 778/867 |
| 2021 | 35.01% 51/740 |
-9.44% 478/580 |
37.46% 22/659 |
-2.51% 273/704 |
11.24% 51/740 |
| 2020 | - - |
- - |
- - |
- - |
9.77% 365/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈发展新动能股票C VS. 东吴新产业精选股票A(580008) |